Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice

Research output: Contribution to journalJournal articlepeer-review


  1. Vaginal microbiome following orally administered probiotic

    Research output: Contribution to journalJournal articlepeer-review

  2. Socioeconomic functioning in patients with brain abscess - a nationwide, population-based cohort study in Denmark

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

The mouse ascending urinary tract infection model was used to study the pharmacokinetic/pharmacodynamic (PKPD) relationships of the effect of ciprofloxacin in subcutaneous treatment for 3 days with varying doses and dosing intervals against a susceptible Escherichia coli strain (MIC, 0.032 mg/liter). Further, a humanized dose of ciprofloxacin was administered for 3 days against three E. coli strains with low-level resistance, i.e., MICs of 0.06, 0.25, and 1 mg/liter, respectively. Against the susceptible isolate, ciprofloxacin was highly effective in clearing the urine with daily doses from 10 mg/kg, but the dosing regimen had to be divided into at least two doses for optimal effect. Ciprofloxacin could not clear the urine or kidneys for the low-level-resistant strains. PKPD correlations with all strains combined showed that for the AUC24/MIC there was a slightly higher correlation with effect in urine and kidneys (R2, 0.71 and 0.69, respectively) than the %T>MIC (R2, 0.41 and 0.61, respectively). Equal correlations for the two PKPD indices were found for reduction of colony counts (CFU) in the bladder tissue, but not even the highest dose of 28 mg/kg × 6 could clear the bladder tissue. In conclusion, ciprofloxacin is highly effective in clearing the urine and kidney tissue for fully susceptible E. coli, while even low-level resistance in E. coli obscures this effect. While the effect of ciprofloxacin is mostly AUC/MIC driven against E. coli infection in the urinary tract, the effect in urine depends on the presence of ciprofloxacin in the urine during most of a 24-h period.

Original languageEnglish
Article numbere01804-20
JournalAntimicrobial Agents and Chemotherapy
Issue number1
Publication statusPublished - Jan 2021

    Research areas

  • Ciprofloxacin, Ciprofloxacin resistance, E. coli, Escherichia coli, Experimental mouse model, PKPD, Urinary tract infection

ID: 62326874